Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference

Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1...

Related Keywords

New York ,United States ,Scott Hutton ,Biodesix Inc ,Nasdaq ,Chief Executive Officer ,Healthcare Conference ,Chat Date ,Chat Time ,Intercontinental New York Barclay ,Nodify Lung ,Nodule Risk Assessment ,Private Securities Litigation Reform Act ,Risk Factors ,Markets ,